$HLN

10 Best Up and Coming Stocks to Invest In Right Now

BNN Bloomberg CEO Colin Stewart of JC Clark said inflation above trend and reduced odds of a Fed rate cut support a cautious market view, with speculation in semiconductors and the SpaceX IPO. The article then lists “up and coming” stocks, including Haleon (HLN) and Sunbelt Rentals (SUNB), citing Haleon’s Microsoft (MSFT) AI collaboration and SUNB’s planned private senior notes offering.

Original reporting
Published Jul 10, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 10, 2026, 10:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
10 Best Up and Coming Stocks to Invest In Right Now — source image
Decision brief

The 30-second read

$HLNBullishLow
01

Why it matters

HLN’s Microsoft collaboration is a strategic AI enablement update that may support longer-term operational improvements, but the text lacks financial metrics. SUNB’s intended private senior notes offering is a capital-structure action that could affect leverage and funding costs, but the text lacks pricing and proceeds details.

02

Market read

The only actionable trading inputs are the disclosed corporate actions, but both lack key deal terms or financial targets, limiting near-term decision quality.

03

What to watch

For SUNB, the market will focus on note size, coupon, maturity, and whether proceeds refinance expensive debt. For HLN, investors will want measurable KPIs from the Microsoft AI integration, not just capability expansion.

Relevance 4/10Novelty 4/10Timing: after-hours/next-session positioning around the disclosed June 1 and June 6 corporate updates

Background

The article is framed around a cautious macro view (inflation above trend, reduced odds of Fed cuts) and late-cycle speculation concerns, then lists two company-specific items (HLN partnership, SUNB planned notes).

Company-level read

Ticker impact

$HLNBullishMedium confidence
Context

Haleon announced a five-year collaboration with Microsoft to scale its digital, data, and AI capabilities across consumer health operations.

Expected impact

Likely modest positive bias for sentiment, with limited immediate repricing absent quantified guidance.

Evidence & confidence

The disclosed fact is a partnership and AI infrastructure scaling plan, which can support longer-term efficiency and product insights, but no revenue, margin, or timeline milestones are provided.

$SUNBNeutralLow confidence
Context

Sunbelt Rentals said it intends to launch a private offering of two series of benchmark-sized senior notes for general corporate purposes.

Expected impact

Near-term reaction likely muted until deal size and pricing are known.

Evidence & confidence

The article confirms intent to issue notes, yet provides no pricing, proceeds amount, or refinancing impact details that would drive valuation.

Market effects

AI partnerships in consumer healthcare and capital-structure actions in equipment rental both reinforce that investors are scrutinizing valuation and balance-sheet moves amid higher-for-longer rate expectations.

Primarily US-listed large-cap sentiment; no direct regional spillover described.

Microsoft-linked AI scaling and global consumer health operations imply international execution risk, but no specific geography-level impact is quantified.

Counterpoint

These are promotional-style “up and coming” picks; without deal pricing (SUNB) or quantified financial impact (HLN), the trading edge may be limited.

Key entities

  • Haleon

    Announced a five-year collaboration with Microsoft to scale digital, data, and AI capabilities in consumer health operations.

  • Microsoft

    Partnered with Haleon to provide cloud and AI tools, including Microsoft 365 Copilot, for automation and productivity.

  • Sunbelt Rentals Holdings Inc.

    Announced intention to launch a private offering of two series of benchmark-sized senior notes for general corporate purposes.

Related articles

$HLNMed

Haleon Invests ₹2,000 Crore in New India Manufacturing Plant

Haleon said it will invest about ₹2,000 crore to build its first dedicated manufacturing plant in India, aiming to expand local production and distribution. The company reported mid-teen growth in India in the quarter ended June 2026, with Sensodyne oral health sales up over 20% in the first half. It is also pushing lower-priced packs to drive volume.

$HLNMed

Sensodyne maker Haleon slips as sales growth concerns overshadow profit beat By Reuters

Reuters reports Haleon shares fell after concerns about meeting sales targets. The consumer health company said first-half organic revenue grew 2.6% and adjusted operating profit rose to £1.36 billion versus £1.32 billion expected. It needs stronger second-half growth to reach a 4% to 6% medium-term target, amid weak Europe demand and a 6.5% respiratory sales decline.

$HLNHighAI 9/10

Haleon H1 Results: Adjusted EPS rises 16.7% to $0.14

Haleon reported adjusted EPS of $0.14 for H1, up 16.7% from $0.12, and sales of $7.533 billion, up 6.0% year over year and far above an analyst consensus of $3.600 billion. The company also announced a new five-year collaboration with Microsoft to expand digital, data and AI capabilities using Azure and Copilot.

$HLNMed

Why is Haleon stock down today? By Investing.com

Haleon shares fell 2.2% to 371.5p after the company reported H1 2026 results. Organic revenue grew 2.6% versus a £5.62bn analyst estimate, with Q2 organic sales up 3.1% but below a 3.2% consensus. Pricing missed expectations. Haleon reaffirmed 2026 guidance and set a 2.4p interim dividend; analysts cited by Investing.com include Deutsche Bank and JPMorgan.

$HLNMed

Haleon hails Sensodyne-boosted revenue rise as profit beats consensus

Haleon reported higher interim dividend and revenue growth in 1H 2026, citing Sensodyne-led momentum. Pretax profit slipped 1.8% to GBP1.06bn, while adjusted pretax profit rose 12% to GBP1.25bn, above consensus GBP1.21bn. Revenue rose 2.2% to GBP5.60bn. Interim dividend increased 9.1% to 2.4p. Outlook unchanged.